Interpretation and use of natriuretic peptides in non-congestive heart failure settings - sprookjes - yvandenbroek - TriplyDB

Interpretation and use of natriuretic peptides in non-congestive heart failure settings

Interpretation and use of natriuretic peptides in non-congestive heart failure settings

http://www.wikidata.org/entity/Q33670478

about

Long-term outcome of single-chamber atrial pacing compared with dual-chamber pacing in patients with sinus-node dysfunction and intact atrioventricular node conduction Impact of chronic obstructive pulmonary diseases on left ventricular diastolic function in hospitalized elderly patients.Increased B-type natriuretic peptide and decreased proteinuria might reflect decreased capillary leakage and is associated with a better outcome in patients with severe burns Predictors of Peak Troponin Level in Acute Coronary Syndromes: Prior Aspirin Use and SYNTAX Score.Generation of a hypomorphic model of propionic acidemia amenable to gene therapy testing.A review on B-type natriuretic peptide monitoring: assays and biosensors B-type natriuretic peptide and echocardiography reflect volume changes during pregnancy.An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).Natriuretic peptides: Diagnostic and therapeutic use.Elevation of NT-proBNP and cardiac troponins in sepsis-related deaths: a forensic perspective.Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.The Role of NT-proBNP in the Diagnosis of Ventricular Arrhythmias in Patients with Systemic Sclerosis.The role of plasma N-terminal brain natriuretic pro-peptide in diagnosing elderly patients with acute exacerbation of COPD concurrent with left heart failure

P2860

Q34373458-54F435FA-C705-473E-BCEC-7E8943C55920 Q34787441-1643BF30-A687-4192-A3DC-9DE79028C19D Q36070360-A80A5AA4-22AA-4B25-A034-72BC0A4FC043 Q36593847-57EA8875-A8D4-4768-91CE-A410875E7ECC Q37001608-73B1371F-C7D0-448B-993F-25771F9DC677 Q37171880-E4BC61BC-973D-4351-B1B4-B0B3ED050323 Q38962450-40C76ED2-F750-4F85-A193-6C077C72696A Q38973132-62870E1C-A9F5-419D-975C-B655A769736F Q39581832-F81DD9B0-1838-4779-A0F4-EEDC40E08E61 Q39899030-868FA1E0-5CFA-45F0-8975-B0A3A39EDC33 Q40803261-D92871EE-19F3-452C-9A0C-E6960A61C485 Q41466512-BB35B0C6-F21D-425A-93B3-B92893CEA1F4 Q57071195-C51F9237-98D6-432F-A05F-79C2D1F88EE2

P2860

Interpretation and use of natriuretic peptides in non-congestive heart failure settings

http://www.wikidata.org/entity/Q33670478

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Interpretation and use of natriuretic peptides in non-congestive heart failure settings

@ast

Interpretation and use of natriuretic peptides in non-congestive heart failure settings

@en

type

label

Interpretation and use of natriuretic peptides in non-congestive heart failure settings

@ast

Interpretation and use of natriuretic peptides in non-congestive heart failure settings

@en

prefLabel

Interpretation and use of natriuretic peptides in non-congestive heart failure settings

@ast

Interpretation and use of natriuretic peptides in non-congestive heart failure settings

@en

P1433

Q33670478-B6029E39-FABF-4AD6-B264-159CA6779C76

P1476

Q33670478-8773AEBF-414F-4583-AF14-4277FA070DD1

P2093

Q33670478-2BE6F641-E04D-41F3-B8C3-B3C33B9FAD76

Q33670478-51C388A4-94F9-430C-B85E-282690E63019

Q33670478-61B48BB7-ADEA-44DA-96E9-C6E0555D5AD5

Q33670478-9CD46F79-7520-4068-A1D4-E39F8035683D

P275

Q33670478-1B49A811-96F0-405D-99B8-0C6589608ACE

P2860

Q33670478-00139870-D664-4683-B54F-58CC05224898

Q33670478-01390153-53B7-40EF-A320-53FA149FBC1C

Q33670478-07B068DB-C67E-4588-BFA9-CAD53815D645

Q33670478-08563A88-2FFA-4760-AB2A-116BBFF2F63E

Q33670478-0EFBAFDA-6254-4D70-9E0F-EFB9E30412A4

Q33670478-164E104B-C4E8-4473-99E8-A287A8669B23

Q33670478-1B26924B-77B2-456D-A6FC-A8CF954877B1

Q33670478-1B343EB5-928F-4BF4-8BB0-9DF61684A5AB

Q33670478-1BB0EEC8-2D31-401A-963A-3DACFFDD2A0A

Q33670478-20158C09-F9EA-4E06-A905-087EAA6B4D9A

P304

Q33670478-0B64A836-546D-42D2-81BA-BAA3B154B7B2

P31

Q33670478-9834C455-CB65-451B-88D6-86D0B8DEDBF6

P356

Q33670478-22322056-7B16-4BB5-A9F0-3FC14C29C1BB

P433

Q33670478-723695B6-33C9-4BD3-B250-E47B39E904D2

P478

Q33670478-B0DF47E7-7FA9-4DCA-9F87-AC3A17167F1F

P50

Q33670478-8EA5B408-13F6-402C-9B25-1E0F1CCDC60B

P5008

Q33670478-14A49E87-D724-413E-B5A7-FD1C5FE7577A

P577

Q33670478-54DD94F4-7815-4F1C-AAB7-B4825303B0DA

P5875

Q33670478-560EE7CE-E20D-4F37-A8FC-F26750BC6843

P698

Q33670478-8D3C6152-4F29-408A-B0D3-AC04D22FAD4F

P921

Q33670478-6ABD5135-000F-413B-9560-E92D890A40C1

Q33670478-BCE2AF6B-D9CF-4227-88C2-C530ED334DAD

Q33670478-CD68F7CF-C5A8-4657-9C0D-68FDDED0B855

P932

Q33670478-21DD72A1-02D3-4CA1-A0A5-6CD8283C884D

P356

YMJ.2010.51.2.151

P1433

Yonsei Medical Journal

P1476

Interpretation and use of natriuretic peptides in non-congestive heart failure settings

@en

P2093

Ching-Wang Hsu

http://www.w3.org/2001/XMLSchema#string

Shi-Jye Chu

http://www.w3.org/2001/XMLSchema#string

Shu-Meng Cheng

http://www.w3.org/2001/XMLSchema#string

Yen-Yue Lin

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 3.0 Unported

P2860

Diagnostic utility of B-type natriuretic peptide in critically ill patients with pulmonary edema: a prospective cohort study.

Brain-type natriuretic peptide secretion following febrile and afebrile seizures - a new marker in childhood epilepsy?

NT-pro-BNP for differential diagnosis in patients with syncope.

Hormones and hemodynamics in heart failure.

Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure

Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study

Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

Natriuretic peptides, respiratory disease, and the right heart.

N-terminal pro-brain natriuretic peptide as an indicator of right ventricular dysfunction.

Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients.

P304

151-163

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3349/YMJ.2010.51.2.151

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2010-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41623584

http://www.w3.org/2001/XMLSchema#string

P698

20191004

http://www.w3.org/2001/XMLSchema#string

P921

P932

2824858

http://www.w3.org/2001/XMLSchema#string